Table 4. Comparative efficacy of cabergoline (CAB) and bromocriptine (BCR) among patients with macroprolactinomas from the Brazilian Multicenter Study on Hyperprolactinemia.

Outcome	CAB (n = 117)	BCR (n = 133)	p-value
PRL normalization	77.8%	59.4%	0.042
Tumor reduction > 50%	80%	58.7%	0.048
Complete tumor disappearance	57.5%	34.7%	0.034

Adapted from Ref. 34.